Global Health Limited
Символ: MEDANTA.NS
NSE
1407
INRРыночная цена сегодня
83.0259
Коэффициент P/E
0.0000
PEG Ratio
377.79B
Капитал MRK
- 0.00%
Доходность DIV
Global Health Limited (MEDANTA-NS) финансовые отчеты
Балансовый отчет
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 13107.8 | 5118.1 | 2893 | |||||
balance-sheet.row.short-term-investments | 0 | 5435.4 | 3923.8 | 2198.3 | |||||
balance-sheet.row.net-receivables | 0 | 1942 | 2423.8 | 1655 | |||||
balance-sheet.row.inventory | 0 | 603.7 | 533.9 | 397.6 | |||||
balance-sheet.row.other-current-assets | 0 | 141.3 | 41.5 | 1730.7 | |||||
balance-sheet.row.total-current-assets | 0 | 15794.9 | 8117.2 | 5021.3 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 23719 | 22088.5 | 20722.4 | |||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.intangible-assets | 0 | 51.7 | 62.7 | 72.5 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 51.7 | 62.7 | 72.5 | |||||
balance-sheet.row.long-term-investments | 0 | -5005.5 | -3818.9 | -2009.8 | |||||
balance-sheet.row.tax-assets | 0 | 257.1 | 277.9 | 257.4 | |||||
balance-sheet.row.other-non-current-assets | 0 | 6342.6 | 4727.8 | 2877.2 | |||||
balance-sheet.row.total-non-current-assets | 0 | 25364.8 | 23337.9 | 21919.7 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 41159.6 | 31455.2 | 26941 | |||||
balance-sheet.row.account-payables | 0 | 1946.9 | 1343.3 | 1315.5 | |||||
balance-sheet.row.short-term-debt | 0 | 1393.6 | 1055.9 | 1029.5 | |||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.long-term-debt-total | 0 | 9825.9 | 10033.3 | 8284.2 | |||||
Deferred Revenue Non Current | 0 | 669.7 | 218.7 | 363.4 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 983.5 | 23.7 | 14.1 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 11152 | 11100.3 | 9071 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 2797.3 | 2710.6 | 2867.8 | |||||
balance-sheet.row.total-liab | 0 | 16877.6 | 15295.1 | 13117.6 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 325 | |||||
balance-sheet.row.common-stock | 0 | 536.4 | 506.4 | 820.9 | |||||
balance-sheet.row.retained-earnings | 0 | 12837.9 | 9529.6 | 7689.8 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 237.3 | 274.5 | 442.5 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 10670.5 | 5849.6 | 4545.2 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 24282.1 | 16160.1 | 13823.4 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 41159.6 | 31455.2 | 26941 | |||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-equity | 0 | 24282.1 | 16160.1 | 13823.4 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 429.9 | 104.9 | 188.6 | |||||
balance-sheet.row.total-debt | 0 | 11219.5 | 11089.3 | 9313.8 | |||||
balance-sheet.row.net-debt | 0 | 3547.1 | 9894.9 | 8619.1 |
Отчет о движении денежных средств
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 4492.9 | 2805.6 | 324.6 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 1499.1 | 1297.1 | 1232.1 | |||||
cash-flows.row.deferred-income-tax | 0 | -7.5 | -874.5 | 131.7 | |||||
cash-flows.row.stock-based-compensation | 0 | 7.5 | 17.4 | 37.9 | |||||
cash-flows.row.change-in-working-capital | 0 | 1028.2 | -667.7 | 365.9 | |||||
cash-flows.row.account-receivables | 0 | -214.6 | -495.6 | 102.9 | |||||
cash-flows.row.inventory | 0 | -69.8 | -136.3 | -12.4 | |||||
cash-flows.row.account-payables | 0 | 603.6 | 27.8 | 8.1 | |||||
cash-flows.row.other-working-capital | 0 | 709 | -63.5 | 267.4 | |||||
cash-flows.row.other-non-cash-items | 0 | -582.6 | 534.7 | 325.4 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2359.9 | -2744.8 | -1457.4 | |||||
cash-flows.row.acquisitions-net | 0 | 8 | 13.8 | 38 | |||||
cash-flows.row.purchases-of-investments | 0 | -1416.1 | -1725.4 | -1172.8 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | -8 | 83.7 | 50.4 | |||||
cash-flows.row.other-investing-activites | 0 | 352.5 | 163.8 | 150.3 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -3423.4 | -4208.9 | -2391.5 | |||||
cash-flows.row.debt-repayment | 0 | -666.5 | -198.9 | -30.2 | |||||
cash-flows.row.common-stock-issued | 0 | 4785.5 | 379.5 | 2.4 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-financing-activites | 0 | -662.6 | 1415.2 | -779.4 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3456.4 | 1595.9 | -807.2 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||
cash-flows.row.net-change-in-cash | 0 | 6478.1 | 499.7 | -781 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 7672.4 | 1194.3 | 694.7 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1194.3 | 694.7 | 1475.7 | |||||
cash-flows.row.operating-cash-flow | 0 | 6445.2 | 3112.6 | 2417.7 | |||||
cash-flows.row.capital-expenditure | 0 | -2359.9 | -2744.8 | -1457.4 | |||||
cash-flows.row.free-cash-flow | 0 | 4085.3 | 367.9 | 960.3 |
Строка отчета о прибылях и убытках
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 26942.5 | 21559.7 | 14306.1 | |||||
income-statement-row.row.cost-of-revenue | 0 | 6252.8 | 5429.3 | 3485.6 | |||||
income-statement-row.row.gross-profit | 0 | 20689.6 | 16130.4 | 10820.6 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | 649.1 | 122.4 | 80 | |||||
income-statement-row.row.operating-expenses | 0 | 15990.5 | 12730.5 | 9893.6 | |||||
income-statement-row.row.cost-and-expenses | 0 | 22243.3 | 18159.8 | 13379.2 | |||||
income-statement-row.row.interest-income | 0 | 346.2 | 167.2 | 177.6 | |||||
income-statement-row.row.interest-expense | 0 | 779.2 | 789.5 | 671 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -855.4 | -594.3 | -602.3 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | 649.1 | 122.4 | 80 | |||||
income-statement-row.row.total-operating-expenses | 0 | -855.4 | -594.3 | -602.3 | |||||
income-statement-row.row.interest-expense | 0 | 779.2 | 789.5 | 671 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 1499.1 | 1297.1 | 1232.1 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 5348.3 | 3399.9 | 927 | |||||
income-statement-row.row.income-before-tax | 0 | 4492.9 | 2805.6 | 324.6 | |||||
income-statement-row.row.income-tax-expense | 0 | 1232.1 | 843.6 | 36.6 | |||||
income-statement-row.row.net-income | 0 | 3260.8 | 1962 | 288.1 |
Часто задаваемые вопросы
Что такое Global Health Limited (MEDANTA.NS) общие активы?
Global Health Limited (MEDANTA.NS) общие активы - 41159640000.000.
Какова годовая выручка предприятия?
Годовая выручка - N/A.
Какова норма прибыли компании?
Норма прибыли компании - 0.768.
Что такое свободный денежный поток компании?
Свободный денежный поток - 12.311.
Что такое норма чистой прибыли предприятия?
Норма чистой прибыли - 0.143.
Что такое общий доход компании?
Общая выручка - 0.226.
Что такое Global Health Limited (MEDANTA.NS) чистая прибыль (чистый доход)?
Чистая прибыль (чистый доход) - 3260793000.000.
Что такое общий долг компании?
Общий долг - 11219519000.000.
Что такое операционные расходы?
Операционные расходы - 15990499000.000.
Какова цифра денежных средств компании?
Денежные средства предприятия - 0.000.